SCHEMBL29964253

SCHEMBL29964253

Cc1cc(-c2cc(-c3ccc4c(c3)CCNC4=O)c(N)nc2F)cc2c1CCN(C)C2

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PARP10 Q53GL7 8/20 0.40
PARP11 Q9NR21 8/20 0.40
MAP4K1 Q92918 2/20 0.40
MAPK1 P28482 1/20 0.40
MAPKAPK2 P49137 5/20 0.40
HSP90AA1 P07900 1/20 0.40
HSP90AB1 P08238 1/20 0.40
MAPK9 P45984 1/20 0.38
GRM5 P41594 1/20 0.38
DAPK3 O43293 1/20 0.36
NTRK1 P04629 1/20 0.36
PIM1 P11309 1/20 0.36
FLT3 P36888 1/20 0.36
GSK3B P49841 1/20 0.36
ROCK1 Q13464 1/20 0.36
CLK4 Q9HAZ1 1/20 0.36
GABRG2 P18507 1/20 0.36
GABRB3 P28472 1/20 0.36
GABRA5 P31644 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29964992 0.88 PARP10 (0.43) PARP10PARP11MAPK1MAPKAPK2HSP90AA1
SCHEMBL31079175 0.87 MAPKAPK2 (0.38) PARP10PARP11MAPK1MAPKAPK2MAPK9
SCHEMBL27159816 0.87 MAP4K1 (0.40) PARP10PARP11MAP4K1MAPK1MAPKAPK2
SCHEMBL29914792 0.87 MAP4K1 (0.40) PARP10PARP11MAP4K1MAPK1MAPKAPK2
SCHEMBL29964927 0.86 PARP10 (0.44) PARP10PARP11MAPK1MAPKAPK2HSP90AA1
SCHEMBL31079008 0.86 MAPKAPK2 (0.35) PARP10PARP11MAP4K1MAPK1MAPKAPK2
SCHEMBL29964535 0.85 PARP10 (0.42) PARP10PARP11MAPK1MAPKAPK2MAPK9
SCHEMBL31079103 0.83 PARP10 (0.55) PARP10PARP11MAPK1MAPKAPK2MAPK9
SCHEMBL29964678 0.81 MAPK1 (0.45) PARP10PARP11MAPK1MAPKAPK2MAPK9
SCHEMBL29964638 0.80 MAPKAPK2 (0.42) PARP10PARP11MAPK1MAPKAPK2MAPK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240343704-A1 HALO-SUBSTITUTED AMINO PYRIDINE COMPOUNDS AS INHIBITORS OF THE HAEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) ONTARIO INSTITUTE FOR CANCER RESEARCH (OICR) (CA) 2024-10-17 US disclosed
WO-2022226668-A1 HALO-SUBSTITUTED AMINO PYRIDINE COMPOUNDS AS INHIBITORS OF THE HAEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) ONTARIO INSTITUTE FOR CANCER RESEARCH (OICR) (CA) 2022-11-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240343704-A1 HALO-SUBSTITUTED AMINO PYRIDINE COMPOUNDS AS INHIBITORS OF THE HAEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) CMPK1, WNK1, AAK1 PARP10 2072/4885PARP11 1176/4885MAP4K1 45/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.